Pfs48/45 in Matrix-M / University of Oxford - LARVOL DELTA

A Study of the Plasmodium Falciparum Malaria Vaccine Candidate Pfs48/45 in Matrix-M Adjuvant in the UK (clinicaltrials.gov) - P1 | N=17 | Terminated | Sponsor: University of Oxford | N=30 ➔ 17 | Recruiting ➔ Terminated; Significant delays in vaccine adjuvant supply due to an out of specification within the context of the grant timeline. Limited safety and immunological data could be accrued from incomplete regimens.

Enrollment change • Trial termination • Infectious Disease • Malaria

A Study of the Plasmodium Falciparum Malaria Vaccine Candidate Pfs48/45 in Matrix-M Adjuvant in the UK (clinicaltrials.gov) - P1 | N=30 | Recruiting | Sponsor: University of Oxford | Not yet recruiting ➔ Recruiting | Initiation date: May 2022 ➔ Nov 2022

Enrollment open • Trial initiation date • Infectious Disease • Malaria

A Study of the Plasmodium Falciparum Malaria Vaccine Candidate Pfs48/45 in Matrix-M Adjuvant in the UK (clinicaltrials.gov) - P1 | N=30 | Not yet recruiting | Sponsor: University of Oxford

New P1 trial • Infectious Disease • Malaria